ly 300164 has been researched along with lamotrigine in 1 studies
| Studies (ly 300164) | Trials (ly 300164) | Recent Studies (post-2010) (ly 300164) | Studies (lamotrigine) | Trials (lamotrigine) | Recent Studies (post-2010) (lamotrigine) |
|---|---|---|---|---|---|
| 73 | 7 | 12 | 3,550 | 501 | 1,351 |
| Protein | Taxonomy | ly 300164 (IC50) | lamotrigine (IC50) |
|---|---|---|---|
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowicz, KK; Czuczwar, SJ; Sawulski, C; Swiader, M; Turski, WA; Zgrajka, W | 1 |
1 other study(ies) available for ly 300164 and lamotrigine
| Article | Year |
|---|---|
Influence of several convulsants on the protective activity of a non-competitive AMPA/kainate antagonist, LY 300164, and lamotrigine against maximal electroshock in mice.
Topics: Aminophylline; Animals; Anticonvulsants; Benzodiazepines; Bicuculline; Convulsants; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; GABA Antagonists; Lamotrigine; Male; Mice; Picrotoxin; Protective Agents; Receptors, AMPA; Strychnine; Triazines | 2002 |